Interest of the Immunoscore® as a Post-operative Complementary Tool for the Detection of the Risk of Recurrence in Patients With Nonmetastatic Colorectal Cancer

ConditionNon Metastatic Colorectal Cancer

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18-80

SponsorHospital St. Joseph, Marseille, France

About this trial

Evaluate the patient care recommandation induced by the IMMUNOSCORE® result

Eligibility criteria

Qualifiers

age between 18 and 80 inclusive;

histologically confirmed colon adenocarcinoma;

having undergone a curative resection of stage I, II or III colorectal cancer;

diagnosed T1 / T2 / T3 / T4 and N0 / N1 / N2;

Disqualifiers

pregnant or breastfeeding women

legal incapacity or physical, psychological, social or geographical conditions preventing the patient from signing the consent or completing the study.

history of other solid tumor within 3 years before inclusion, with the exception of in-situ cancer of the cervix and skin cancers (basal or squamous) treated and controlled

person subject to a safeguard measure.

Trial design

Treatments tested in this trial

IMMUNOSCORE®

Treatment groups

100 Participants

are divided into 1 treatment group

Sponsors and collaborators

Hospital St. Joseph, Marseille, France

Lead sponsor

Source ClinicalTrials.gov